Lantu Biopharma
Clinical trials sponsored by Lantu Biopharma, explained in plain language.
-
One-Time gene therapy aims to free patients from lifelong blood transfusions
Disease control Recruiting nowThis trial is testing a one-time gene therapy for people with severe beta-thalassemia who depend on regular blood transfusions. Doctors will collect a patient's own blood stem cells, use a modified virus to insert a healthy hemoglobin gene into them, and then return the cells to …
Phase: PHASE1, PHASE2 • Sponsor: Lantu Biopharma • Aim: Disease control
Last updated Apr 04, 2026 06:21 UTC
-
Gene therapy for devastating muscle disease tested in Real-World settings
Disease control Recruiting nowThis study is observing how well a gene therapy called Vesemnogene works for spinal muscular atrophy (SMA) in real-world settings in lower-income countries. Researchers will follow 15 patients with SMA who receive this one-time treatment to monitor their safety and see if they ac…
Phase: PHASE3 • Sponsor: Lantu Biopharma • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC